{
    "2018-10-22": [
        [
            {
                "time": "",
                "original_text": "混改中的紫鑫药业人参板块引质疑 总经理回复称将是强势增长的“蓄水池”",
                "features": {
                    "keywords": [
                        "混改",
                        "紫鑫药业",
                        "人参板块",
                        "质疑",
                        "总经理",
                        "强势增长",
                        "蓄水池"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}